Ocean Biomedical (NASDAQ: OCEA) Announces Share Price Target Increase to $17.63 by Fundamental Research Corp. on Positive Results from Independent Study Showing Glioblastoma Tumor Suppression, Received Patents, and Recent Financing Providence, RI, June 21, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: “OCEA”), a next-generation biopharma company working to accelerate the development and commercialization of...

Clinical Trial Guide Launches online to help patients and caregivers navigate the clinical trial process This new resource at clinicaltrialguide.com seeks to transform the way patients and their caregivers understand and navigate the often overly complicated process of clinical trial...

Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech Established D-Crypt™ platform will be used to develop a proof-of-concept targeting three of the top five viral vaccine protein candidates for CoronavirusCurrent Regulatory environment could lead to...